TROP2‐positive epithelia have been linked with stem cell properties in normal tissues of several organs [9, 10, 11] and TROP2 expression has been linked with an adverse prognosis in a variety of cancers [12, 13, 14]. The gene discussed is TACSTD2; the disease is cancer.